Revenue Summary of Qiagen N.V.

Qiagen N.V.'s latest annual revenue in 2023 was 1.96 Billion USD , down -8.23% from previous year.
Qiagen N.V.'s latest quarterly revenue in 2024 Q2 was 496.34 Million USD , up 8.18% from previous quarter.
Qiagen N.V. reported a annual revenue of 2.14 Billion USD in annual revenue 2022, down -4.89% from previous year.
Qiagen N.V. reported a annual revenue of 2.25 Billion USD in annual revenue 2021, up 20.39% from previous year.
Qiagen N.V. reported a quarterly revenue of 496.34 Million USD for 2024 Q2, up 8.18% from previous quarter.
Qiagen N.V. reported a quarterly revenue of 485.39 Million USD for 2023 Q1, down -2.53% from previous quarter.

Annual Revenue Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Revenue of Qiagen N.V. (2023 - 1995)

Year	Revenue	Revenue Growth
2023	1.96 Billion USD	-8.23%
2022	2.14 Billion USD	-4.89%
2021	2.25 Billion USD	20.39%
2020	1.87 Billion USD	22.53%
2019	1.52 Billion USD	1.64%
2018	1.5 Billion USD	5.95%
2017	1.41 Billion USD	5.95%
2016	1.33 Billion USD	4.45%
2015	1.28 Billion USD	-4.74%
2014	1.34 Billion USD	3.29%
2013	1.3 Billion USD	3.79%
2012	1.25 Billion USD	7.24%
2011	1.16 Billion USD	7.57%
2010	1.08 Billion USD	7.69%
2009	1 Billion USD	13.09%
2008	892.97 Million USD	37.43%
2007	649.77 Million USD	39.5%
2006	465.77 Million USD	16.91%
2005	398.39 Million USD	4.67%
2004	380.62 Million USD	8.32%
2003	351.4 Million USD	17.68%
2002	298.6 Million USD	13.21%
2001	263.77 Million USD	29.28%
2000	204.03 Million USD	41.73%
1999	143.96 Million USD	30.64%
1998	110.2 Million USD	48.32%
1997	74.3 Million USD	37.08%
1996	54.2 Million USD	46.49%
1995	37 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	458.79 Million USD	-9.89%
2024 Q2	496.34 Million USD	8.18%
2023 Q1	485.39 Million USD	-2.53%
2023 Q3	475.89 Million USD	-3.83%
2023 Q4	509.16 Million USD	6.99%
2023 FY	1.96 Billion USD	-8.23%
2023 Q2	494.85 Million USD	1.95%
2022 Q1	628.39 Million USD	7.9%
2022 Q4	497.98 Million USD	-0.33%
2022 FY	2.14 Billion USD	-4.89%
2022 Q2	515.51 Million USD	-17.96%
2022 Q3	499.63 Million USD	-3.08%
2021 Q2	567.3 Million USD	0.02%
2021 Q4	582.39 Million USD	8.91%
2021 FY	2.25 Billion USD	20.39%
2021 Q1	567.2 Million USD	-0.71%
2021 Q3	534.74 Million USD	-5.74%
2020 Q2	443.25 Million USD	19.12%
2020 FY	1.87 Billion USD	22.53%
2020 Q1	372.09 Million USD	-10.01%
2020 Q3	483.76 Million USD	9.14%
2020 Q4	571.23 Million USD	18.08%
2019 FY	1.52 Billion USD	1.64%
2019 Q1	348.65 Million USD	-13.52%
2019 Q2	381.61 Million USD	9.45%
2019 Q3	382.68 Million USD	0.28%
2019 Q4	413.47 Million USD	8.04%
2018 Q4	403.17 Million USD	6.68%
2018 Q3	377.91 Million USD	0.19%
2018 Q2	377.19 Million USD	9.79%
2018 Q1	343.56 Million USD	-13.43%
2018 FY	1.5 Billion USD	5.95%
2017 Q1	307.7 Million USD	-16.05%
2017 Q4	396.86 Million USD	9.04%
2017 FY	1.41 Billion USD	5.95%
2017 Q3	363.97 Million USD	4.29%
2017 Q2	348.99 Million USD	13.42%
2016 Q4	366.51 Million USD	8.22%
2016 Q1	298.37 Million USD	-14.39%
2016 Q2	334.41 Million USD	12.08%
2016 Q3	338.68 Million USD	1.28%
2016 FY	1.33 Billion USD	4.45%
2015 Q1	298.42 Million USD	-17.2%
2015 FY	1.28 Billion USD	-4.74%
2015 Q3	314.56 Million USD	-1.53%
2015 Q2	319.45 Million USD	7.05%
2015 Q4	348.54 Million USD	10.8%
2014 Q1	317.07 Million USD	-12.19%
2014 Q4	360.41 Million USD	7.12%
2014 FY	1.34 Billion USD	3.29%
2014 Q2	330.83 Million USD	4.34%
2014 Q3	336.45 Million USD	1.7%
2013 Q1	303.57 Million USD	-12.4%
2013 FY	1.3 Billion USD	3.79%
2013 Q4	361.08 Million USD	12.1%
2013 Q3	322.11 Million USD	2.19%
2013 Q2	315.21 Million USD	3.83%
2012 FY	1.25 Billion USD	7.24%
2012 Q3	304.28 Million USD	-0.95%
2012 Q2	307.21 Million USD	3.64%
2012 Q1	296.42 Million USD	-11.36%
2012 Q4	346.53 Million USD	13.88%
2011 Q4	334.42 Million USD	15.76%
2011 Q1	264.26 Million USD	-7.61%
2011 Q2	282.17 Million USD	6.78%
2011 FY	1.16 Billion USD	7.57%
2011 Q3	288.88 Million USD	2.38%
2010 Q1	264.36 Million USD	-8.55%
2010 Q2	262.71 Million USD	-0.62%
2010 Q3	274.31 Million USD	4.42%
2010 FY	1.08 Billion USD	7.69%
2010 Q4	286.03 Million USD	4.27%
2009 Q2	240.15 Million USD	8.7%
2009 Q3	259.65 Million USD	8.12%
2009 FY	1 Billion USD	13.09%
2009 Q4	289.07 Million USD	11.33%
2009 Q1	220.93 Million USD	-6.85%
2008 Q4	237.18 Million USD	2.76%
2008 FY	892.97 Million USD	37.43%
2008 Q1	207.1 Million USD	-1.48%
2008 Q3	230.8 Million USD	5.93%
2008 Q2	217.88 Million USD	5.21%
2007 FY	649.77 Million USD	39.5%
2007 Q4	210.22 Million USD	19.02%
2007 Q2	135.03 Million USD	5.6%
2007 Q1	127.87 Million USD	1.58%
2007 Q3	176.63 Million USD	30.8%
2006 Q4	125.89 Million USD	6.74%
2006 Q2	113.23 Million USD	4.16%
2006 Q1	108.71 Million USD	4.19%
2006 Q3	117.93 Million USD	4.16%
2006 FY	465.77 Million USD	16.91%
2005 Q4	104.34 Million USD	5.75%
2005 FY	398.39 Million USD	4.67%
2005 Q1	95.02 Million USD	-0.53%
2005 Q2	100.35 Million USD	5.61%
2005 Q3	98.67 Million USD	-1.68%
2004 Q4	95.53 Million USD	5.67%
2004 Q3	90.4 Million USD	-8.35%
2004 Q2	98.63 Million USD	2.68%
2004 Q1	96.05 Million USD	0.99%
2004 FY	380.62 Million USD	8.32%
2003 FY	351.4 Million USD	17.68%
2003 Q2	86.25 Million USD	8.37%
2003 Q1	79.58 Million USD	1.45%
2003 Q4	95.12 Million USD	5.17%
2003 Q3	90.44 Million USD	4.86%
2002 FY	298.6 Million USD	13.21%
2002 Q1	70.53 Million USD	-0.99%
2002 Q2	72.74 Million USD	3.14%
2002 Q3	76.88 Million USD	5.68%
2002 Q4	78.44 Million USD	2.04%
2001 Q3	63.34 Million USD	-4.09%
2001 FY	263.77 Million USD	29.28%
2001 Q4	71.23 Million USD	12.46%
2001 Q1	63.14 Million USD	11.36%
2001 Q2	66.04 Million USD	4.59%
2000 Q3	50.5 Million USD	1.4%
2000 FY	204.03 Million USD	41.73%
2000 Q4	56.7 Million USD	12.28%
2000 Q2	49.8 Million USD	17.93%
2000 Q1	42.23 Million USD	7.94%
1999 FY	143.96 Million USD	30.64%
1999 Q1	34 Million USD	12.96%
1999 Q2	35.2 Million USD	3.53%
1999 Q3	35.64 Million USD	1.25%
1999 Q4	39.12 Million USD	9.78%
1998 Q3	28.3 Million USD	8.02%
1998 Q2	26.2 Million USD	9.17%
1998 Q1	24 Million USD	18.23%
1998 FY	110.2 Million USD	48.32%
1998 Q4	30.1 Million USD	6.36%
1997 Q2	17.9 Million USD	4.68%
1997 Q1	17.1 Million USD	14.0%
1997 Q4	20.3 Million USD	6.84%
1997 Q3	19 Million USD	6.15%
1997 FY	74.3 Million USD	37.08%
1996 Q4	15 Million USD	5.63%
1996 Q1	12.5 Million USD	0.0%
1996 FY	54.2 Million USD	46.49%
1996 Q3	14.2 Million USD	12.7%
1996 Q2	12.6 Million USD	0.8%
1995 FY	37 Million USD	0.0%

Peer Revenue Comparison of Qiagen N.V.

Name	Revenue	Revenue Difference
Agilent Technologies, Inc.	6.83 Billion USD	71.238%
Charles River Laboratories International, Inc.	4.12 Billion USD	52.407%
Quest Diagnostics Incorporated	9.25 Billion USD	78.758%
Danaher Corporation	23.89 Billion USD	91.773%
Enzo Biochem, Inc.	31.9 Million USD	-6059.498%
IQVIA Holdings Inc.	14.98 Billion USD	86.884%
Laboratory Corporation of America Holdings	12.16 Billion USD	83.84%
Mettler-Toledo International Inc.	3.78 Billion USD	48.122%
Revvity, Inc.	2.75 Billion USD	28.549%
Thermo Fisher Scientific Inc.	42.85 Billion USD	95.414%
Waters Corporation	2.95 Billion USD	33.524%

Global Stocks Search

Qiagen N.V. (QGEN)

Revenue Summary of Qiagen N.V.

Annual Revenue Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Revenue of Qiagen N.V. (2023 - 1995)

Peer Revenue Comparison of Qiagen N.V.